Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH)

PHASE2TerminatedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

March 17, 2021

Primary Completion Date

August 16, 2023

Study Completion Date

February 9, 2024

Conditions
Nonalcoholic Steatohepatitis (NASH)
Interventions
DRUG

BMS-986263

Specified dose on specified days

OTHER

Placebo

Specified dose on specified days

Trial Locations (112)

0

Azienda Ospedaliera Universitaria Di Messina G. Martino-D.A.I. Medicina Interna, Messina

168

Local Institution, Rome

333

Local Institution - 0004, Taoyuan District

807

Local Institution - 0001, Kaohsiung City

1181

Local Institution - 0089, Ciudad de Buenos Aires

1879

Local Institution - 0209, Quilmes

1888

Local Institution - 0126, San Juan Bautista

2650

Local Institution - 0009, Edegem

3001

Local Institution - 0133, Leuven

3010

Local Institution - 0074, Bern

6900

Local Institution - 0102, Lugano

9000

Local Institution - 0006, Ghent

10002

Local Institution, Taipei

10016

NYU Langone Health-Department of Medicine, New York

10029

Local Institution, New York

11217

Local Institution, Taipei

13353

Local Institution - 0091, Berlin

14203

Research Foundation of SUNY - University of Buffalo, Buffalo

19104

Local Institution - 0177, Philadelphia

19107

Local Institution - 0017, Philadelphia

21202

Local Institution - 0150, Baltimore

22332

Local Institution - 0093, Incheon

23538

Local Institution - 0194, Lübeck

24105

Local Institution - 0073, Kiel

28007

Local Institution - 0080, Madrid

28034

Local Institution - 0039, Madrid

28222

Local Institution - 0038, Madrid

28557

Local Institution - 0206, Morehead City

29010

Local Institution - 0036, Málaga

30625

Local Institution - 0096, Hanover

32789

Local Institution - 0025, Winter Park

33136

Local Institution - 0061, Miami

34211

Florida Research Institute, Lakewood Rch

34748

Local Institution - 0024, Leesburg

37411

University Diabetes & Endocrine Consultants, Chattanooga

39008

Local Institution - 0037, Santander

40138

Local Institution - 0054, Bologna

41013

Local Institution - 0041, Seville

45147

Local Institution - 0099, Essen

46010

Local Institution - 0035, Valencia

46026

Local Institution - 0043, Valencia

52242

Local Institution - 0121, Iowa City

54292

Local Institution - 0204, Trier

54500

Local Institution - 0029, Vandœuvre-lès-Nancy

55131

Local Institution - 0071, Mainz

56124

Local Institution - 0051, Pisa

60590

Local Institution - 0082, Frankfurt am Main

64111

Local Institution - 0077, Kansas City

67098

Local Institution - 0137, Strasbourg

68198

Local Institution - 0186, Omaha

69004

Local Institution - 0094, Lyon

75013

Local Institution - 0101, Paris

75014

Local Institution - 0105, Paris

75203

Local Institution - 0171, Dallas

77030

Local Institution - 0109, Houston

78215

Local Institution - 0013, San Antonio

78504

Local Institution, McAllen

81377

Local Institution - 0060, Munich

85013

Local Institution, Phoenix

85224

Arizona Clinical Trials - Tucson, Chandler

Local Institution - 0173, Chandler

The Institute for Liver Health-The Institute for Liver Health, Chandler

90067

GastroIntestinal BioSciences, Los Angeles

90127

Local Institution - 0115, Palermo

92037

Local Institution - 0140, La Jolla

93534

Local Institution - 0205, Lancaster

94000

Local Institution - 0202, Créteil

94063

Local Institution - 0143, Redwood City

3436212

Local Institution - 0056, Haifa

4941492

Local Institution - 0076, Petah Tikva

5008513

Local Institution - 0193, Gifu

5262100

Local Institution - 0058, Ramat Gan

6423906

Local Institution - 0057, Tel Aviv

7348551

Local Institution - 0026, Hiroshima

8908520

Local Institution - 0135, Kagoshima

14049900

Local Institution, Ribeirão Preto

90035004

Local Institution, Porto Alegre

232980341

Local Institution - 0122, Richmond

02721

Local Institution, Fall River

C1280AEB

Local Institution - 0059, Buenos Aires

40110-060

Local Institution - 0083, Salvador

95700-084

Local Institution - 0182, Bento Gonçalves

14780-320

Local Institution - 0187, Barretos

18618.687

Local Institution - 0188, Botucatu

09715-090

Local Institution - 0196, São Bernardo do Campo

01.308-050

Local Institution - 0120, São Paulo

05652000

Local Institution, São Paulo

V8V 3M9

Local Institution - 0128, Victoria

M6H 3M1

Local Institution - 0097, Toronto

06200

Local Institution - 0031, Nice

791-0295

Local Institution - 0200, Tōon

830-0011

Local Institution - 0048, Kurume

0608648

Local Institution - 0049, Sapporo

028-3695

Local Institution - 0127, Shiwagun Yahabatyo

236-0004

Local Institution - 0075, Yokohama

390-8621

Local Institution - 0155, Matsumoto

634-0813

Local Institution - 0111, Kashihara

591-8025

Local Institution - 0163, Sakai

113-8519

Local Institution - 0125, Bunkyō

105-8470

Local Institution - 0138, Minato-ku

030-8553

Local Institution - 0199, Aomori

602-8566

Local Institution - 0131, Kyoto

990-9585

Local Institution - 0132, Yamagata

00927

Local Institution - 0012, San Juan

03722

Local Institution - 0066, Seodaemun-gu

04401

Local Institution - 0090, Seoul

08035

Local Institution - 0040, Barcelona

NG7 2UH

Local Institution - 0011, Nottingham

HU3 2JZ

Local Institution - 0034, Hull

L9 7AL

Local Institution - 0124, Liverpool

SE5 9RS

Local Institution - 0005, London

SO16 6YD

Local Institution, Southampton

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT04267393 - Safety and Effectiveness of BMS-986263 in Adults With Compensated Cirrhosis (Liver Disease) From Nonalcoholic Steatohepatitis (NASH) | Biotech Hunter | Biotech Hunter